EXIANT

What this means for you

This application is over — abandoned 27 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88381334

Mark type

Stylized text

Filed

11 Apr 2019

Published for opposition

11 Feb 2020

Abandoned

27 Nov 2023

Attorney of record

Louis C. Cullman

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders for use in oncology; pharmaceutical mineral supplements and preparations for use in oncology; none of the foregoing for diagnostic use
• Class 009 — Scientific and electric apparatus: Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; none of the foregoing for diagnostic use
• Class 010 — Medical apparatus: Drug delivery devices in the nature of drug delivery systems; drug delivery systems; injection device for pharmaceutical preparations; injectors for medical purposes in the nature of medical fluid injectors; none of the foregoing for diagnostic use
• Class 035 — Advertising and business services: Online wholesale services by direct solicitation by salespersons directed to end-users featuring pharmaceuticals; referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products in the nature of medical referrals; business administration of prescription drug co-payment programs; business administration of patient reimbursement programs; referral services in the field of co-pay assistance programs in the nature of providing insurance agent referrals; providing an online commercial information directory in the field of patient support featuring information regarding healthcare providers, sites at which subcutaneous injections could be administered and retail pharmacies or specialty pharmacies where patients could obtain pharmaceutical preparations; none of the foregoing relating to diagnostic products or diagnostics
• Class 036 — Insurance and financial services: Providing healthcare administration, namely, providing insurance verification and prior authorization services for others; none of the foregoing relating to diagnostic products or diagnostics; none of the foregoing relating to diagnostic products or diagnostics
• Class 041 — Education and entertainment services: Educational services, namely, development and dissemination of printed educational materials of others in the fields of pharmaceutical products and treatment of medical disorders; conducting classes, seminars, conferences, and workshops in the field of the use of prescription pharmaceutical products for medical disorders, in the field of cancer, patient care; educational and entertainment services, namely, providing a motivational and educational speaker featuring information regarding medical disorders; training services in the field of patient support services relating to treatment of medical disorders; providing on-line electronic newsletters delivered by email, and blogs in the medical, pharmaceutical and health fields; none of the foregoing relating to diagnostic products or diagnostics
• Class 042 — Scientific and technological services: Medical and pharmaceutical research services; pharmaceutical research and development; none of the foregoing relating to diagnostic products or diagnostics
• Class 044 — Medical, beauty and agricultural services: Patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; providing patient support services relating to cancer and cancer treatment in the nature of an Internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing a website featuring information in the medical and health fields; providing a website featuring information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing information in the medical field and information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing health information; providing patients with information in the medical field; providing health information, namely, providing data on the genetics and genetic sequencing of cancer tumors and cells; none of the foregoing relating to diagnostic products or diagnostics

Owner

• Spectrum Pharmaceuticals, Inc., Irvine, CA, US
• Spectrum Pharmaceuticals, Inc., Irvine, CA, US

Prosecution history

• 27 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 27 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
• 09 Aug 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 05 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 04 May 2023 — SOU EXTENSION 5 GRANTED
• 27 Apr 2023 — SOU EXTENSION 5 FILED
• 03 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 27 Apr 2023 — SOU TEAS EXTENSION RECEIVED
• 29 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 27 Oct 2022 — SOU EXTENSION 4 GRANTED
• 27 Oct 2022 — SOU EXTENSION 4 FILED
• 27 Oct 2022 — SOU TEAS EXTENSION RECEIVED
• 28 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 26 Apr 2022 — SOU EXTENSION 3 GRANTED
• 26 Apr 2022 — SOU EXTENSION 3 FILED